# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 186


For regulation 226 (amendment of regulation 345 (immunity from civil liability)) substitute—
“226. In regulation 345(5), for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/186 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-186
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.